Valuation: IDEXX Laboratories, Inc.

Market Cap 43.79B 220B 38.97B 36.12B 32.73B 61.51B 4,148B 62.54B 433B 170B 2,171B 164B 161B 6,925B P/E 2026 *
37.6x
P/E 2027 * 33.3x
Enterprise Value 44.15B 222B 39.3B 36.42B 33.01B 62.03B 4,183B 63.07B 437B 172B 2,189B 166B 162B 6,983B EV / Sales 2026 *
9.35x
EV / Sales 2027 * 8.48x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day+2.81%
1 week+5.82%
Current month+1.55%
1 month+3.49%
3 months-0.26%
6 months-6.14%
Current year-27.66%
1 week 531.51
Extreme 531.51
546.43
1 month 509.99
Extreme 509.99
546.43
Current year 509.99
Extreme 509.99
773.97
1 year 509.99
Extreme 509.99
813.6
3 years 439
Extreme 439
813.6
5 years 336.6
Extreme 336.6
813.6
10 years 225.06
Extreme 225.055
813.6
Manager TitleAgeSince
Chief Executive Officer 52 11/05/2026
Director of Finance/CFO 43 28/02/2025
Chief Operating Officer 58 31/12/2024
Director TitleAgeSince
Chairman 65 11/05/2026
Director/Board Member 64 14/07/2013
Director/Board Member 73 10/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
+2.81%+5.82% - - 43.79B
-1.19%+0.69%-20.22%+6.76% 180B
+1.51%+1.38%-1.70%+29.70% 114B
+1.70%+7.31%-20.46%+14.12% 114B
-1.02%+2.87%-52.05%-7.70% 78.39B
+0.58%+3.64%+4.50%+81.25% 64.88B
+1.60%+3.73%+17.39%+76.86% 54.02B
+1.21%+3.07%+1.11%-25.33% 51.96B
-0.20%+6.88%-13.57%+30.24% 43.79B
-0.92%+0.42%+24.83%-0.64% 32.45B
Average +0.61%+2.96%-6.69%+22.81% 81.49B
Weighted average by Cap. +0.45%+2.97%-11.94%+20.47%

Financials

2026 *2027 *
Net sales 4.72B 23.7B 4.21B 3.9B 3.53B 6.64B 448B 6.75B 46.77B 18.37B 234B 17.72B 17.35B 747B 5.15B 25.84B 4.58B 4.25B 3.85B 7.24B 488B 7.36B 50.98B 20.03B 255B 19.32B 18.92B 815B
Net income 1.18B 5.91B 1.05B 972M 881M 1.66B 112B 1.68B 11.67B 4.58B 58.44B 4.42B 4.33B 186B 1.31B 6.59B 1.17B 1.08B 982M 1.85B 125B 1.88B 13.01B 5.11B 65.16B 4.93B 4.83B 208B
Net Debt 368M 1.84B 327M 303M 275M 516M 34.82B 525M 3.64B 1.43B 18.22B 1.38B 1.35B 58.13B -98.49M -494M -87.67M -81.25M -73.62M -138M -9.33B -141M -975M -383M -4.88B -369M -362M -15.58B
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
15/10/26 R$546.43 +2.81% 3
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
555.80USD
Average target price
705.50USD
Spread / Average Target
+26.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IDEXX Laboratories, Inc.